Business Description
City Therapeutics is a Cambridge-based biopharmaceutical company founded in 2023 that develops RNA interference medicines designed to silence the genes responsible for serious diseases. The company focuses on conditions affecting the blood, eyes, and central nervous system, with several drug candidates currently advancing through development. City Therapeutics works alongside major partners, including Bausch + Lomb and Biogen, to bring its treatments to patients across a range of medical fields.
